Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dow

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Nature Genetics|May 13, 1999
Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UKD J Dow, N Lindsey, N J Cairns, et al.
Clinical Pharmacy|April 1, 1987
Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter studyM L Devine, G J Dow, B R Greenberg, et al.
American Journal of Human Genetics|May 1, 1996
A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United KingdomS J Knight, R J Ritchie, L Chakrabarti, et al.
JMIR Formative Research|July 18, 2022
Virtual Care Prior to and During COVID-19: Cross-sectional Survey of Rural and Urban AdultsKathy L Rush, Cherisse L Seaton, Kendra Corman, et al.
Lancet (London, England)|April 12, 2002
Genetic variations in HLA-B region and hypersensitivity reactions to abacavirSeth Hetherington, Arlene R Hughes, Michael Mosteller, et al.
Schizophrenia Research|January 18, 2011
ADAMTSL3 as a candidate gene for schizophrenia: gene sequencing and ultra-high density association analysis by imputationDavid J Dow, Julie Huxley-Jones, Jamie M Hall, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2015
An international study of the quality of national-level guidelines on driving with medical illnessM J Rapoport, K Weegar, Y Kadulina, et al.
Cell Stem Cell|May 31, 2016
In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution PhasesLuca Biasco, Danilo Pellin, Serena Scala, et al.
American Heart Journal|September 1, 2020
An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trialGrace E Venechuk, Prateeti Khazanie, Robert L Page, et al.
Circulation|November 17, 2020
An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF TrialLarry A Allen, Grace Venechuk, Colleen K McIlvennan, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Nature Genetics|May 13, 1999
Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UKD J Dow, N Lindsey, N J Cairns, et al.
Clinical Pharmacy|April 1, 1987
Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter studyM L Devine, G J Dow, B R Greenberg, et al.
American Journal of Human Genetics|May 1, 1996
A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United KingdomS J Knight, R J Ritchie, L Chakrabarti, et al.
JMIR Formative Research|July 18, 2022
Virtual Care Prior to and During COVID-19: Cross-sectional Survey of Rural and Urban AdultsKathy L Rush, Cherisse L Seaton, Kendra Corman, et al.
Lancet (London, England)|April 12, 2002
Genetic variations in HLA-B region and hypersensitivity reactions to abacavirSeth Hetherington, Arlene R Hughes, Michael Mosteller, et al.
Schizophrenia Research|January 18, 2011
ADAMTSL3 as a candidate gene for schizophrenia: gene sequencing and ultra-high density association analysis by imputationDavid J Dow, Julie Huxley-Jones, Jamie M Hall, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2015
An international study of the quality of national-level guidelines on driving with medical illnessM J Rapoport, K Weegar, Y Kadulina, et al.
Cell Stem Cell|May 31, 2016
In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution PhasesLuca Biasco, Danilo Pellin, Serena Scala, et al.
American Heart Journal|September 1, 2020
An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trialGrace E Venechuk, Prateeti Khazanie, Robert L Page, et al.
Circulation|November 17, 2020
An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF TrialLarry A Allen, Grace Venechuk, Colleen K McIlvennan, et al.
Pageof 17